180 Life Valuation
| ATNF Stock | USD 1.56 0.02 1.27% |
Based on Macroaxis valuation methodology, the entity appears to be undervalued. 180 Life Sciences owns a latest Real Value of $21.1 per share. The recent price of the entity is $1.56. Our model approximates the value of 180 Life Sciences from evaluating the entity fundamentals such as Return On Asset of -0.63, shares owned by institutions of 3.46 %, and Price To Book of 1.34 X as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that 180 Life's price fluctuation is slightly risky at this time. Calculation of the real value of 180 Life Sciences is based on 3 months time horizon. Increasing 180 Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the 180 stock is determined by what a typical buyer is willing to pay for full or partial control of 180 Life Sciences. Since 180 Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of 180 Stock. However, 180 Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.56 | Real 21.1 | Hype 1.2 |
The real value of 180 Stock, also known as its intrinsic value, is the underlying worth of 180 Life Sciences Company, which is reflected in its stock price. It is based on 180 Life's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of 180 Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of 180 Life Sciences helps investors to forecast how 180 stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of 180 Life more accurately as focusing exclusively on 180 Life's fundamentals will not take into account other important factors: 180 Life Total Value Analysis
180 Life Sciences is presently estimated to have valuation of 8.08 M with market capitalization of 5.21 M, debt of 1.05 M, and cash on hands of 1.63 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the 180 Life fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.08 M | 5.21 M | 1.05 M | 1.63 M |
180 Life Asset Utilization
One of the ways to look at asset utilization of 180 is to check how much profit was generated for every dollar of assets it reports. 180 Life Sciences owns a negative utilization of current and long term assets of -0.63 %, losing $0.00635 for each dollar of current and long term assets held by the entity. Discouraging asset utilization signifies that the company is being less competent with each dollar of current and long term assets it owns. Strictly speaking, asset utilization of 180 Life Sciences shows how wasteful it operates for each dollar spent on its current and long term assets.180 Life Ownership Allocation
180 Life Sciences owns 4.34 % of its outstanding shares held by insiders and 3.46 % owned by institutions.180 Life Profitability Analysis
Net Loss for the year was (19.94 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates 180 Life's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in 180 Life and how it compares across the competition.
About 180 Life Valuation
The stock valuation mechanism determines 180 Life's current worth on a weekly basis. Our valuation model uses a comparative analysis of 180 Life. We calculate exposure to 180 Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of 180 Life's related companies.1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company was incorporated in 2016 and is headquartered in Palo Alto, California. 180 Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
180 Life Growth Indicators
Investing in growth stocks can be very risky. If the company such as 180 Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 379.1 K | |
| Forward Price Earnings | 6.079 |
Complementary Tools for 180 Stock analysis
When running 180 Life's price analysis, check to measure 180 Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 180 Life is operating at the current time. Most of 180 Life's value examination focuses on studying past and present price action to predict the probability of 180 Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 180 Life's price. Additionally, you may evaluate how the addition of 180 Life to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |